Wheeler Bio

Wheeler Bio provides integrated process development and cGMP manufacturing services focused on accelerating the transition of antibody-based therapeutics from discovery through IND-enabling studies into early clinical trials. Its Modular CMC™ and Portable CMC® platforms streamline tech transfer, reduce timelines/costs, and de-risk early-stage biomanufacturing. The company has demonstrated success in helping clients file PIND/IND within a year by providing rapid material supply and robust analytical/process development support. It does not have its own drug pipeline but serves as an enabling partner for biotech innovators.